VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
PLURPluri Inc.
$2.02$18M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

PLUR logoPluri Inc.(PLUR)Earnings, Financials & Key Ratios

PLUR•NASDAQ
Price updated Jun 19, 2026
SectorHealthcareIndustryBiotechnologySub-IndustryCell and Gene Therapy Developers
AboutPluri Inc., a biotechnology company, focuses on the development of placenta-based cell therapy product candidates for the treatment of multiple inflammatory, muscle injuries, and hematologic conditions. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trials for the muscle recovery after surgery for hip fracture; in Phase II clinical trails for the treatment of acute respiratory distress syndrome associated with COVID-19; and in Phase I/II clinical trial for treatment of steroid-refractory graft versus host disease. It also develops PLX-R18 for incomplete hematopoietic recovery following hematopoietic cell transplantation, as well as a solution for the treatment of acute radiation syndrome. The company was formerly known as Pluristem Therapeutics Inc. and changed its name to Pluri Inc. in July 2022. Pluri Inc. was incorporated in 2001 and is based in Haifa, Israel.Show more
  • Revenue$1M+309.8%
  • EBITDA-$22M+0.2%
  • Net Income-$23M-8.1%
  • EPS (Diluted)-3.56+10.8%
  • Gross Margin48.95%-50.4%
  • EBITDA Margin-1636.23%+75.6%
  • Operating Margin-1659.88%+75.6%
  • Net Margin-1690.34%+73.6%
  • ROE-992.66%-392.2%

PLUR Key Insights

Pluri Inc. (PLUR) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Strong 5Y sales CAGR of 125.3%

✗Weaknesses

  • ✗Weak Piotroski F-Score: 2/9
  • ✗Negative free cash flow
  • ✗Weak momentum: RS Rating 8 (bottom 8%)
  • ✗Shares diluted 20.9% in last year
  • ✗Trading more than 30% below 52-week high
  • ✗Low asset turnover indicates capital-intensive operations

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when PLUR posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

PLUR Price & Volume

Pluri Inc. (PLUR) stock price & volume — 10-year historical chart

Loading chart...

PLUR Growth Metrics

Pluri Inc. (PLUR) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years13.43%
5 Years125.33%
3 Years78.73%
TTM4.35%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-26.31%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM25.45%

Return on Capital

10 Years-78.09%
5 Years-68.82%
3 Years-71.16%
Last Year-107.06%

PLUR Recent Earnings

Pluri Inc. (PLUR) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 3/12 qtrs (38%)●Beat Revenue 1/12 qtrs (14%)
Q1 2026Latest
Feb 12, 2026
Metric
Actual
Est
EPS
$0.71-9.2%
$0.65
Rev
$198,000-69.0%
$638,000
Q4 2025
Nov 12, 2025
Metric
Actual
Est
EPS
$0.65+12.2%
$0.74
Rev
$316,000-50.5%
$638,000
Q4 2025
Sep 17, 2025
Metric
Actual
Est
EPS
$2.62-303.1%
$0.65
Rev
$398,000-37.6%
$638,000
Q2 2025
May 13, 2025
Metric
Actual
Est
EPS
$0.94-28.8%
$0.73
Rev
$427,000+6.8%
$400,000
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q1 2026LatestFeb 12, 2026
$0.71vs $0.65-9.2%
$198,000vs $638,000-69.0%
Q4 2025Nov 12, 2025
$0.65vs $0.74+12.2%
$316,000vs $638,000-50.5%
Q4 2025Sep 17, 2025
$2.62vs $0.65-303.1%
$398,000vs $638,000-37.6%
Q2 2025May 13, 2025
$0.94vs $0.73-28.8%
$427,000vs $400,000+6.8%
Based on last 12 quarters of dataView full earnings history →

PLUR Peer Comparison

Pluri Inc. (PLUR) competitors in Cell and Gene Therapy Developers — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
FATE logoFATEFate Therapeutics, Inc.Direct Competitor243.61M2.09-1.82-51.24%-20.57%-58.89%0.38
NTLA logoNTLAIntellia Therapeutics, Inc.Direct Competitor1.76B15.67-4.1116.92%-5.97%-57.27%0.14
BEAM logoBEAMBeam Therapeutics Inc.Direct Competitor3.51B34.14-42.15120.01%-49.17%-5.89%0.24
EDIT logoEDITEditas Medicine, Inc.Direct Competitor263.37M2.69-1.4925.39%-281.59%-6.77%2.81
CRSP logoCRSPCRISPR Therapeutics AGDirect Competitor5.22B54.09-8.36-89.97%-138.57%-30.88%0.21
IOVA logoIOVAIovance Biotherapeutics, Inc.Product Competitor1.4B3.91-3.5960.6%-123.9%-50.17%0.07
CELC logoCELCCelcuity Inc.Product Competitor4.28B87.76-23.22-244.61%1.94
RCKT logoRCKTRocket Pharmaceuticals, Inc.Product Competitor365.8M3.35-1.67-70.79%0.09

Compare PLUR vs Peers

Pluri Inc. (PLUR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs FATE

Most directly comparable listed peer for PLUR.

Scale Benchmark

vs TMO

Larger-name benchmark to compare PLUR against a more recognizable public peer.

Peer Set

Compare Top 5

vs FATE, NTLA, BEAM, EDIT

PLUR Income Statement

Pluri Inc. (PLUR) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricJun'17Jun'18Jun'19Jun'20Jun'21Jun'22Jun'23Jun'24Jun'25TTM
Sales/Revenue
050K54K23K0234K287K326K1.34M1.08M
Revenue Growth %
-100%-8%-57.41%-100%-22.65%13.59%309.82%4.35%
Cost of Goods Sold
2.18M2K2K1.57M1.37M1.05M9K4K682K874K
COGS % of Revenue
-4%3.7%6826.09%-450%3.14%1.23%51.05%-
Gross Profit
-2.18M▲ 0%
48K▲ 102.2%
52K▲ 8.3%
-1.55M▼ 3075.0%
-1.37M▲ 11.4%
-819K▲ 40.2%
278K▲ 133.9%
322K▲ 15.8%
654K▲ 103.1%
205K▲ 0%
Gross Margin %
-96%96.3%-6726.09%--350%96.86%98.77%48.95%19%
Gross Profit Growth %
-179.25%102.2%8.33%-3075%11.44%40.22%133.94%15.83%103.11%-
Operating Expenses
28.02M33.78M35.58M27.93M49.25M40.77M27.52M22.48M22.83M26.23M
OpEx % of Revenue
-67558%65896.3%121430.43%-17424.79%9590.24%6895.71%1708.83%-
Selling, General & Admin
6.93M11.19M9.16M7.8M20.56M17.45M11.78M10.03M9.98M10.51M
SG&A % of Revenue
-22386%16957.41%33934.78%-7457.26%4104.18%3077.91%746.93%-
Research & Development
21.09M22.63M24.59M20.12M30.07M24.38M15.74M12.45M12.85M15.76M
R&D % of Revenue
-45258%45529.63%87495.65%-10417.52%5486.06%3817.79%961.9%-
Other Operating Expenses
0000-1.37M-1.05M0000
Operating Income
-28.02M▲ 0%
-33.73M▼ 20.4%
-35.53M▼ 5.3%
-29.48M▲ 17.0%
-50.62M▼ 71.7%
-41.59M▲ 17.8%
-27.25M▲ 34.5%
-22.16M▲ 18.7%
-22.18M▼ 0.1%
-26.03M▲ 0%
Operating Margin %
--67462%-65800%-128156.52%--17774.79%-9493.38%-6796.93%-1659.88%-2412.14%
Operating Income Growth %
-20.16%-20.39%-5.34%17.04%-71.74%17.84%34.49%18.67%-0.08%-
EBITDA
-25.84M-31.71M-33.57M-27.91M-49.25M-40.54M-26.88M-21.91M-21.86M-25.66M
EBITDA Margin %
--63426%-62166.67%-121330.43%--17324.79%-9367.25%-6719.33%-1636.23%-2377.85%
EBITDA Growth %
-22.07%-22.72%-5.86%16.87%-76.5%17.69%33.69%18.52%0.21%-20.33%
D&A (Non-Cash Add-back)
2.18M2.02M1.96M1.57M1.37M1.05M362K253K316K370K
EBIT
-27.75M-26.13M-35.31M-28.96M-49.79M-40.49M-28.04M-20.48M-22.38M-26.95M
Net Interest Income
0-661K356K188K414K-306K241K448K271K167K
Interest Income
122K276K385K384K492K581K1.08M1.31M1.14M623K
Interest Expense
0937K29K196K78K887K843K866K873K456K
Other Income/Expense
205K7.61M225K324K758K219K-1.64M814K-1.08M-939K
Pretax Income
-27.81M▲ 0%
-26.13M▲ 6.1%
-35.31M▼ 35.1%
-29.15M▲ 17.4%
-49.87M▼ 71.1%
-41.37M▲ 17.0%
-28.89M▲ 30.2%
-21.34M▲ 26.1%
-23.25M▼ 9.0%
-26.97M▲ 0%
Pretax Margin %
--52252%-65383.33%-126747.83%--17681.2%-10065.16%-6547.24%-1740.64%-2499.17%
Income Tax
-205K0-94K00000-5K-21K
Effective Tax Rate %
0.74%0%0.27%0%0%0%0%0%0.02%0.08%
Net Income
-27.81M▲ 0%
-26.13M▲ 6.1%
-35.31M▼ 35.1%
-29.15M▲ 17.4%
-49.87M▼ 71.1%
-41.24M▲ 17.3%
-28.32M▲ 31.3%
-20.89M▲ 26.2%
-22.58M▼ 8.1%
-26.16M▲ 0%
Net Margin %
--52252%-65383.33%-126747.83%--17624.79%-9867.94%-6407.36%-1690.34%-2424.75%
Net Income Growth %
-19.65%6.07%-35.14%17.43%-71.05%17.29%31.33%26.25%-8.11%-26.31%
Net Income (Continuing)
-27.81M-26.13M-35.31M-29.15M-49.87M-41.37M-28.89M-21.34M-23.25M-26.95M
Discontinued Operations
0000000000
Minority Interest
000002.15M1.95M5.32M5.98M5.6M
EPS (Diluted)
-25.45▲ 0%
-19.74▲ 22.4%
-23.20▼ 17.5%
-12.80▲ 44.8%
-14.19▼ 10.9%
-10.24▲ 27.8%
-6.18▲ 39.6%
-3.99▲ 35.4%
-3.56▲ 10.8%
-2.60▲ 0%
EPS Growth %
-8.85%22.44%-17.53%44.83%-10.86%27.84%39.65%35.44%10.78%25.45%
EPS (Basic)
-25.45-19.74-23.20-12.80-14.19-10.24-6.18-3.99-3.56-
Diluted Shares Outstanding
1.09M1.32M1.54M2.27M3.51M4.02M4.58M5.24M6.34M10.05M
Basic Shares Outstanding
1.09M1.32M1.54M2.27M3.51M4.02M4.58M5.24M6.34M10.05M
Dividend Payout Ratio
----------

PLUR Balance Sheet

Pluri Inc. (PLUR) balance sheet — assets, liabilities & shareholders' equity

MetricJun'17Jun'18Jun'19Jun'20Jun'21Jun'22Jun'23Jun'24Jun'25TTM
Total Current Assets
29.02M32.04M26.37M48.46M67.37M57.75M41.41M31.11M22.09M10.46M
Cash & Short-Term Investments
26.11M29.9M23.7M46.34M64.95M55.02M40.17M29.98M20.61M9.55M
Cash Only
4.71M8.82M4.11M8.82M31.24M9.77M5.36M6.78M5.89M3.65M
Short-Term Investments
21.4M21.08M19.6M37.51M33.71M45.24M34.81M23.2M14.72M5.9M
Accounts Receivable
1.17M847K1.42M1.61M1.49M1.32M527K638K722K99K
Days Sales Outstanding
-6.18K9.6K25.55K-2.06K670.23714.33197.25108.59
Inventory
00692K0000000
Days Inventory Outstanding
--126.29K-------
Other Current Assets
0021K67K598K1.01M269K262K525K816K
Total Non-Current Assets
8.52M6.92M4.94M17.07M26.17M10.32M9.39M8.42M16.59M15.59M
Property, Plant & Equipment
7.28M5.68M3.84M3.77M2.23M9.01M8.32M7.25M8.72M8.04M
Fixed Asset Turnover
-0.01x0.01x0.01x-0.03x0.03x0.04x0.15x0.13x
Goodwill
000000003.14M3.14M
Intangible Assets
000000002.79M2.66M
Long-Term Investments
403K383K398K12.65M000001.89M
Other Non-Current Assets
838K863K703K643K23.94M1.31M1.07M1.17M1.94M815K
Total Assets
37.53M▲ 0%
38.96M▲ 3.8%
31.31M▼ 19.6%
65.53M▲ 109.3%
93.54M▲ 42.7%
68.06M▼ 27.2%
50.8M▼ 25.4%
39.53M▼ 22.2%
38.68M▼ 2.1%
26.06M▲ 0%
Asset Turnover
-0.00x0.00x0.00x-0.00x0.01x0.01x0.03x0.03x
Asset Growth %
-18.3%3.8%-19.64%109.3%42.74%-27.23%-25.37%-22.19%-2.14%-38.33%
Total Current Liabilities
5.41M8.55M8.16M7.99M11.52M6.83M5.62M4.45M32.33M32.01M
Accounts Payable
1.97M3.26M2.28M1.97M2.53M1.78M1.81M964K866K743K
Days Payables Outstanding
329.62595.13K416.28K457.53672.99618.7373.49K87.97K463.48365.42
Short-Term Debt
0001.02M000027.29M28.03M
Deferred Revenue (Current)
0640K0126K40K112K151K124K341K717K
Other Current Liabilities
687K946K03.02M1.2M1.51M873K702K859K3.01M
Current Ratio
5.36x3.75x3.23x6.07x5.85x8.46x7.37x6.98x0.68x0.33x
Quick Ratio
5.36x3.75x3.15x6.07x5.85x8.46x7.37x6.98x0.68x0.33x
Cash Conversion Cycle
---280.39K-------256.83
Total Non-Current Liabilities
1.87M1.91M1.33M1.44M24.87M29.05M29.88M29.66M7.22M7.05M
Long-Term Debt
000023.85M21.68M23.53M24.03M00
Capital Lease Obligations
000565K100K6.5M5.75M5.03M6.1M23.88M
Deferred Tax Liabilities
00000000415K1.61M
Other Non-Current Liabilities
1.87M1.91M1.33M879K920K867K598K605K703K1.06M
Total Liabilities
7.28M10.45M9.49M9.43M36.39M35.88M35.5M34.11M39.55M39.06M
Total Debt
0001.58M24.58M28.8M29.91M29.61M34.05M33.63M
Net Debt
-4.71M-8.82M-4.11M-7.24M-6.66M19.03M24.55M22.83M28.16M29.98M
Debt / Equity
---0.03x0.43x0.89x1.95x5.47x--2.59x
Debt / EBITDA
----------1.31x
Net Debt / EBITDA
----------1.17x
Interest Coverage
--27.88x-1217.48x-147.73x-638.29x-45.64x-33.27x-23.65x-25.64x-59.09x
Total Equity
30.25M▲ 0%
28.51M▼ 5.8%
21.82M▼ 23.5%
56.1M▲ 157.1%
57.15M▲ 1.9%
32.19M▼ 43.7%
15.3M▼ 52.5%
5.42M▼ 64.6%
-865K▼ 116.0%
-13M▲ 0%
Equity Growth %
-20.72%-5.77%-23.45%157.1%1.87%-43.68%-52.46%-64.61%-115.97%-11986.61%
Book Value per Share
27.6821.5514.1524.6616.268.003.341.03-0.14-1.29
Total Shareholders' Equity
30.25M28.51M21.82M56.1M57.15M30.04M13.36M96K-6.84M-18.6M
Common Stock
1K1K1K0000000
Retained Earnings
-189.57M-215.7M-251M-280.16M-330.02M-371.26M-399.58M-420.47M-443.06M-461M
Treasury Stock
0000000000
Accumulated OCI
2M-11.21M00000000
Minority Interest
000002.15M1.95M5.32M5.98M5.6M

PLUR Cash Flow Statement

Pluri Inc. (PLUR) cash flow — operating, investing & free cash flow history

MetricJun'17Jun'18Jun'19Jun'20Jun'21Jun'22Jun'23Jun'24Jun'25TTM
Cash from Operations
-21.61M-21.38M-29.45M-26.37M-30.91M-36.5M-22.86M-18.02M-18.21M-20.36M
Operating CF Margin %
--42760%-54542.59%-114647.83%--15598.72%-7964.11%-5527.91%-1363.1%-
Operating CF Growth %
-16.68%1.07%-37.76%10.47%-17.22%-18.09%37.38%21.16%-1.05%-71.82%
Net Income
-27.81M-26.13M-35.31M-29.15M-49.87M-41.37M-28.89M-21.34M-23.25M-26.16M
Depreciation & Amortization
2.18M2.02M1.96M1.57M1.37M1.05M362K253K316K498K
Stock-Based Compensation
3.66M6.55M5.15M2.56M13.97M8.91M3.98M2.62M2.14M2.95M
Deferred Taxes
512K-7.57M000-15.18M-5.32M000
Other Non-Cash Items
-14K5K-3K-11K86K15.18M5.32M473K-1.61M3.74M
Working Capital Changes
-134K3.75M-1.25M-1.34M3.53M-5.09M1.69M-21K4.19M-1.23M
Change in Receivables
1.19M978K-121K37K-256K-329K-336K438K-111K85K
Change in Inventory
-24.23M-21.93M0-789K0329K336K000
Change in Payables
-701K1.21M-863K-291K578K-758K-22K-778K-235K-62K
Cash from Investing
4.3M5.57M1.17M-30.46M-7.26M11.78M9.7M10.58M8.03M11.32M
Capital Expenditures
-378K-342K-239K-270K-373K-280K-262K-323K-1.62M-1.33M
CapEx % of Revenue
-684%442.59%1173.91%-119.66%91.29%99.08%121.11%123.08%
Acquisitions
30K-1.94M6K00000373K373K
Investments
----------
Other Investing
30K1.94M-6K-12.24M000000
Cash from Financing
15.8M19.92M23.58M60.87M61.4M7.5M8.02M8.84M9.53M3.79M
Debt Issued (Net)
000024.45M-2.17M0000
Equity Issued (Net)
15.72M18.63M23.47M58.16M36.59M08.02M91K9.58M3.4M
Dividends Paid
0000000000
Share Repurchases
0000000000
Other Financing
79K1.29M115K2.71M364K9.67M08.75M-47K382K
Net Change in Cash
-1.52M▲ 0%
4.11M▲ 371.4%
-4.7M▼ 214.3%
4.04M▲ 186.0%
22.61M▲ 459.2%
-20.43M▼ 190.3%
-5.16M▲ 74.8%
1.42M▲ 127.4%
-475K▼ 133.6%
-5.14M▲ 0%
Free Cash Flow
-21.99M▲ 0%
-21.72M▲ 1.2%
-29.69M▼ 36.7%
-26.64M▲ 10.3%
-31.28M▼ 17.4%
-36.78M▼ 17.6%
-23.12M▲ 37.1%
-18.34M▲ 20.7%
-19.83M▼ 8.1%
-21.69M▲ 0%
FCF Margin %
--43444%-54985.19%-115821.74%--15718.38%-8055.4%-5626.99%-1484.21%-2010.1%
FCF Growth %
-8.47%1.21%-36.69%10.28%-17.43%-17.57%37.14%20.65%-8.1%-19.07%
FCF per Share
-20.12-16.42-19.26-11.71-8.90-9.14-5.05-3.50-3.13-2.16
FCF Conversion (FCF/Net Income)
0.78x0.82x0.83x0.90x0.62x0.89x0.81x0.86x0.81x0.83x
Interest Paid
0000000000
Taxes Paid
-28K-27K-10K-10K000000

PLUR Key Ratios

Pluri Inc. (PLUR) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)
-81.32%-88.93%-140.31%-74.82%-88.06%-92.33%-119.28%-201.67%-992.66%364.34%
Return on Invested Capital (ROIC)
-73.12%-111.86%-142.5%-66.41%-76.43%-61.34%-44.88%-48.81%-59.9%-77.41%
Gross Margin
-96%96.3%-6726.09%--350%96.86%98.77%48.95%19%
Net Margin
--52252%-65383.33%-126747.83%--17624.79%-9867.94%-6407.36%-1690.34%-2424.75%
Debt / Equity
---0.03x0.43x0.89x1.95x5.47x--2.59x
Interest Coverage
--27.88x-1217.48x-147.73x-638.29x-45.64x-33.27x-23.65x-25.64x-59.09x
FCF Conversion
0.78x0.82x0.83x0.90x0.62x0.89x0.81x0.86x0.81x0.83x
Revenue Growth
-100%-8%-57.41%-100%-22.65%13.59%309.82%4.35%
Related:PLUR Dividend History·PLUR Revenue History·PLUR Price History·PLUR P/E History·PLUR Financial Ratios·PLUR Institutional Holders

PLUR SEC Filings & Documents

Pluri Inc. (PLUR) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Mar 27, 2026·SEC

Material company update

Mar 2, 2026·SEC

Material company update

Jan 22, 2026·SEC

10-K Annual Reports

3
FY 2025

Sep 17, 2025·SEC

FY 2024

Sep 18, 2024·SEC

FY 2023

Sep 12, 2023·SEC

10-Q Quarterly Reports

6
FY 2026

May 14, 2026·SEC

FY 2026

Feb 12, 2026·SEC

FY 2025

Nov 12, 2025·SEC

PLUR Frequently Asked Questions

Pluri Inc. (PLUR) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Pluri Inc. (PLUR) reported $1.1M in revenue for fiscal year 2025.

Pluri Inc. (PLUR) grew revenue by 309.8% over the past year. This is strong growth.

Pluri Inc. (PLUR) reported a net loss of $26.2M for fiscal year 2025.

Dividend & Returns

Pluri Inc. (PLUR) has a return on equity (ROE) of -992.7%. Negative ROE indicates the company is unprofitable.

Pluri Inc. (PLUR) had negative free cash flow of $21.7M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in PLUR back in 2002?

Total return calculator · dividends reinvested · 24+ years of data

See returns →

How much would $100/month in PLUR be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →